Pazopanib or placebo in completely resected stage I NSCLC patients: results of the phase II IFCT-0703 trial.
Besse B, Mazières J, Ribassin-Majed L, Barlesi F, Bennouna J, Gervais R, Moreau L, Berard H, Debieuvre D, Molinier O, Moro-Sibilot D, Souquet PJ, Jacquot S, Petit L, Lena H, Pignon JP, Lacas B, Morin F, Milleron B, Zalcman G, Soria JC; Intergroupe Francophone de Cancérologie Thoracique (IFCT).
Besse B, et al. Among authors: lacas b.
Ann Oncol. 2017 May 1;28(5):1078-1083. doi: 10.1093/annonc/mdx070.
Ann Oncol. 2017.
PMID: 28327934
Free article.
Clinical Trial.